BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Diagnosis
36 results:

  • 1. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
    Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
    J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Historical redlining and breast cancer treatment and survival among older women in the United States.
    Bikomeye JC; Zhou Y; McGinley EL; Canales B; Yen TWF; Tarima S; Ponce SB; Beyer KMM
    J Natl Cancer Inst; 2023 Jun; 115(6):652-661. PubMed ID: 36794919
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Expression and Function of StAR in cancerous and Non-cancerous Human and Mouse breast Tissues: New Insights into diagnosis and Treatment of Hormone-Sensitive breast cancer.
    Manna PR; Ramachandran S; Pradeepkiran JA; Molehin D; Castro-Piedras I; Pruitt K; Ganapathy V; Reddy PH
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614200
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary breast sarcoma: A case series.
    Ahuja M; Mallya V; Mandal S; Tomar R; Aggarwal R; Khurana N; Lal P
    Indian J Pathol Microbiol; 2022; 65(1):152-156. PubMed ID: 35074983
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
    Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
    [No Abstract]    [Full Text] [Related]  

  • 6. Problematic breast tumors reassessed in light of novel molecular data.
    Pareja F; Weigelt B; Reis-Filho JS
    Mod Pathol; 2021 Jan; 34(Suppl 1):38-47. PubMed ID: 33024304
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Highly Sensitive and Specific Molecular Test for Mutations in the diagnosis of Thyroid Nodules: A Prospective Study of
    Cho YY; Park SY; Shin JH; Oh YL; Choe JH; Kim JH; Kim JS; Yim HS; Kim YL; Ki CS; Kim TH; Chung JH; Kim SW
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781560
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment.
    Nakaguro M; Tada Y; Faquin WC; Sadow PM; Wirth LJ; Nagao T
    Cancer Cytopathol; 2020 Oct; 128(10):693-703. PubMed ID: 32421944
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Percutaneous contrast-enhanced ultrasound for localization and diagnosis of sentinel lymph node in early breast cancer.
    Liu J; Liu X; He J; Gou B; Luo Y; Deng S; Wen H; Zhou L
    Sci Rep; 2019 Sep; 9(1):13545. PubMed ID: 31537856
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Salivary duct carcinoma: A case report of oncocytic variant with possible treatment implications and review of literature.
    Sekhri R; Ortanca I; Boals C; Agarwal S
    Pathol Res Pract; 2019 Oct; 215(10):152549. PubMed ID: 31495607
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. EAA clinical practice guidelines-gynecomastia evaluation and management.
    Kanakis GA; Nordkap L; Bang AK; Calogero AE; Bártfai G; Corona G; Forti G; Toppari J; Goulis DG; Jørgensen N
    Andrology; 2019 Nov; 7(6):778-793. PubMed ID: 31099174
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification and imaging of miR-155 in the early screening of lung cancer by targeted delivery of octreotide-conjugated chitosan-molecular beacon nanoparticles.
    Zhu HZ; Hou J; Guo Y; Liu X; Jiang FL; Chen GP; Pang XF; Sun JG; Chen ZT
    Drug Deliv; 2018 Nov; 25(1):1974-1983. PubMed ID: 30621480
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Role of Molecular Testing in the Differential diagnosis of Salivary Gland Carcinomas.
    Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
    Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma.
    Kim TH; Lee M; Kwon AY; Choe JH; Kim JH; Kim JS; Hahn SY; Shin JH; Chung MK; Son YI; Ki CS; Yim HS; Kim YL; Chung JH; Kim SW; Oh YL
    Histopathology; 2018 Mar; 72(4):648-661. PubMed ID: 28940583
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland.
    Kasajima A; Cameselle-Teijeiro J; Loidi L; Takahashi Y; Nakashima N; Sato S; Fujishima F; Watanabe M; Nakazawa T; Naganuma H; Kondo T; Kato R; Sasano H
    Endocr Pathol; 2016 Dec; 27(4):325-331. PubMed ID: 26860935
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
    Luk PP; Weston JD; Yu B; Selinger CI; Ekmejian R; Eviston TJ; Lum T; Gao K; Boyer M; O'Toole SA; Clark JR; Gupta R
    Head Neck; 2016 Apr; 38 Suppl 1():E1838-47. PubMed ID: 26699379
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2-, triple positive and triple-negative breast cancer patients.
    Pacheco-Velázquez SC; Gallardo-Pérez JC; Aguilar-Ponce JL; Villarreal P; Ruiz-Godoy L; Pérez-Sánchez M; Marín-Hernández A; Ruiz-García E; Meneses-García A; Moreno-Sánchez R; Rodríguez-Enríquez S
    Int J Oncol; 2014 Dec; 45(6):2549-59. PubMed ID: 25270118
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Correlation of breast cancer axillary lymph node metastases with stem cell mutations.
    Donovan CA; Pommier RF; Schillace R; O'Neill S; Muller P; Alabran JL; Hansen JE; Murphy JA; Naik AM; Vetto JT; Pommier SJ
    JAMA Surg; 2013 Sep; 148(9):873-8. PubMed ID: 23884447
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.
    Hoenerhoff MJ; Chu I; Barkan D; Liu ZY; Datta S; Dimri GP; Green JE
    Oncogene; 2009 Aug; 28(34):3022-32. PubMed ID: 19543317
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. How valid is single nucleotide polymorphism (SNP) diagnosis for the individual risk assessment of breast cancer?
    Tempfer CB; Hefler LA; Schneeberger C; Huber JC
    Gynecol Endocrinol; 2006 Mar; 22(3):155-9. PubMed ID: 16835078
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.